Yahoo
NasdaqGS - Nasdaq Real Time Price USD

The Cooper Companies, Inc. (COO)

60.17 +0.76 (+1.28%)
As of 2:17:37 PM EDT. Market Open.
Trade COO on Coinbase
Chart Range Bar
Loading chart for COO

What's happening with COO?

14m ago
Powered by Yahoo Scout

CooperCompanies replaced CEO Albert White amid activist pressure and reaffirmed fiscal 2026 guidance. The company is preparing to report fourth-quarter results, with analysts expecting lower quarterly EPS despite projected full-year earnings growth.

Powered by Yahoo Scout
  • Previous Close 59.41
  • Open 60.04
  • Bid 54.87 x 200
  • Ask 64.56 x 200
  • Day's Range 59.58 - 60.39
  • 52 Week Range 51.01 - 89.83
  • Volume 704,601
  • Avg. Volume 3,389,489
  • Market Cap (intraday) 11.442B
  • Beta (5Y Monthly) 0.82
  • PE Ratio (TTM) 20.68
  • EPS (TTM) 2.91
  • Earnings Date Sep 9, 2026
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est 65.80
  • Morningstar Rating Rating available with Stock Picks access

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

www.coopercos.com

15,000

Full Time Employees

October 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/29/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

COO
26.58%
S&P 500 (^GSPC)
12.47%

1-Year Return

COO
13.52%
S&P 500 (^GSPC)
11.73%

3-Year Return

COO
21.57%
S&P 500 (^GSPC)
86.99%

5-Year Return

COO
42.25%
S&P 500 (^GSPC)
67.17%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY26
Revenue 1.07B
Earnings 432.8M
Profit Margin 40.59%

Q4

FY25

Q1

FY26

Q2

FY26

Q3

FY26

0
200M
400M
600M
800M
1B
0.0%
10.0%
20.0%
30.0%
40.0%

Analyst Insights

View More

Analyst Price Targets

58.00
65.80 Average
60.17 Current
75.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 10/7/2026
Analyst Barclays
Rating Action Initiated
Rating Equal-Weight
Price Action Announces
Price Target 60

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    13.46%

  • Return on Assets (ttm)

    2.73%

  • Return on Equity (ttm)

    6.84%

  • Revenue (ttm)

    4.24B

  • Net Income Avi to Common (ttm)

    570.3M

  • Diluted EPS (ttm)

    2.91

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    154.7M

  • Total Debt/Equity (mrq)

    33.63%

  • Levered Free Cash Flow (ttm)

    542.65M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: